Suppr超能文献

心脏中的血红素加氧酶-1与一氧化碳:危险信号与促生存之间的平衡作用

Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.

作者信息

Otterbein Leo E, Foresti Roberta, Motterlini Roberto

机构信息

Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215.

Inserm, U955, Equipe 12, Créteil, 94000, France.

出版信息

Circ Res. 2016 Jun 10;118(12):1940-1959. doi: 10.1161/CIRCRESAHA.116.306588.

Abstract

Understanding the processes governing the ability of the heart to repair and regenerate after injury is crucial for developing translational medical solutions. New avenues of exploration include cardiac cell therapy and cellular reprogramming targeting cell death and regeneration. An attractive possibility is the exploitation of cytoprotective genes that exist solely for self-preservation processes and serve to promote and support cell survival. Although the antioxidant and heat-shock proteins are included in this category, one enzyme that has received a great deal of attention as a master protective sentinel is heme oxygenase-1 (HO-1), the rate-limiting step in the catabolism of heme into the bioactive signaling molecules carbon monoxide, biliverdin, and iron. The remarkable cardioprotective effects ascribed to heme oxygenase-1 are best evidenced by its ability to regulate inflammatory processes, cellular signaling, and mitochondrial function ultimately mitigating myocardial tissue injury and the progression of vascular-proliferative disease. We discuss here new insights into the role of heme oxygenase-1 and heme on cardiovascular health, and importantly, how they might be leveraged to promote heart repair after injury.

摘要

了解心脏损伤后修复和再生能力的调控过程对于开发转化医学解决方案至关重要。新的探索途径包括心脏细胞疗法以及针对细胞死亡和再生的细胞重编程。一个有吸引力的可能性是利用仅存在于自我保护过程中、用于促进和支持细胞存活的细胞保护基因。虽然抗氧化蛋白和热休克蛋白属于这一类别,但作为主要保护哨兵而备受关注的一种酶是血红素加氧酶-1(HO-1),它是血红素分解代谢为生物活性信号分子一氧化碳、胆绿素和铁的限速步骤。血红素加氧酶-1具有显著的心脏保护作用,这一点最明显地体现在它能够调节炎症过程、细胞信号传导和线粒体功能,最终减轻心肌组织损伤和血管增殖性疾病的进展。我们在此讨论关于血红素加氧酶-1和血红素在心血管健康中的作用的新见解,以及重要的是,如何利用它们来促进损伤后心脏的修复。

相似文献

1
Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.
Circ Res. 2016 Jun 10;118(12):1940-1959. doi: 10.1161/CIRCRESAHA.116.306588.
2
Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury.
Curr Pharm Des. 2017;23(26):3884-3898. doi: 10.2174/1381612823666170413122439.
3
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation.
Transl Res. 2016 Jan;167(1):7-34. doi: 10.1016/j.trsl.2015.06.011. Epub 2015 Jun 23.
4
Heme oxygenase-1/carbon monoxide as modulators of autophagy and inflammation.
Arch Biochem Biophys. 2019 Dec 15;678:108186. doi: 10.1016/j.abb.2019.108186. Epub 2019 Nov 5.
5
Protective functions of heme oxygenase-1 and carbon monoxide in the respiratory system.
Antioxid Redox Signal. 2007 Dec;9(12):2157-73. doi: 10.1089/ars.2007.1811.
6
Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy.
Am J Respir Cell Mol Biol. 2009 Sep;41(3):251-60. doi: 10.1165/rcmb.2009-0170TR. Epub 2009 Jul 17.
7
Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1.
Vascul Pharmacol. 2019 Jan;112:79-90. doi: 10.1016/j.vph.2018.08.011. Epub 2018 Sep 10.
9
Where is the Clinical Breakthrough of Heme Oxygenase-1 / Carbon Monoxide Therapeutics?
Curr Pharm Des. 2018;24(20):2264-2282. doi: 10.2174/1381612824666180723161811.
10
Heme oxygenase and atherosclerosis.
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1786-95. doi: 10.1161/01.ATV.0000178169.95781.49. Epub 2005 Jul 14.

引用本文的文献

1
Advancements in nanomedicine for modulating ischemic cardiomyopathy therapy.
Mater Today Bio. 2025 Aug 23;34:102238. doi: 10.1016/j.mtbio.2025.102238. eCollection 2025 Oct.
3
Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer.
Dis Res. 2025 Mar;5(1):19-36. doi: 10.54457/dr.202402015. Epub 2025 Jan 17.
4
Unraveling the Roles of HIF-1, HO-1, GLUT-1 and GLUT-4 in Myocardial Protection.
Int J Drug Discov Pharm. 2024 Sep;3(3). doi: 10.53941/ijddp.2024.100016. Epub 2024 Aug 26.
6
Endothelial protein C receptor promotes retinal neovascularization through heme catabolism.
Nat Commun. 2025 Feb 13;16(1):1603. doi: 10.1038/s41467-025-56810-0.
7
Inhibition of MALAT1 facilitates ROS accumulation via the Keap1/HO-1 pathway to enhance photodynamic therapy in secondary hyperparathyroidism.
Noncoding RNA Res. 2025 Jan 8;11:249-261. doi: 10.1016/j.ncrna.2024.12.001. eCollection 2025 Apr.
9
Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology.
Front Immunol. 2024 Oct 24;15:1433113. doi: 10.3389/fimmu.2024.1433113. eCollection 2024.

本文引用的文献

2
Red alert: labile heme is an alarmin.
Curr Opin Immunol. 2016 Feb;38:94-100. doi: 10.1016/j.coi.2015.11.006. Epub 2015 Dec 29.
3
Diverse Nrf2 Activators Coordinated to Cobalt Carbonyls Induce Heme Oxygenase-1 and Release Carbon Monoxide in Vitro and in Vivo.
J Med Chem. 2016 Jan 28;59(2):756-62. doi: 10.1021/acs.jmedchem.5b01509. Epub 2016 Jan 15.
5
Vascular and angiogenic activities of CORM-401, an oxidant-sensitive CO-releasing molecule.
Biochem Pharmacol. 2016 Feb 15;102:64-77. doi: 10.1016/j.bcp.2015.12.014. Epub 2015 Dec 22.
7
Vascular endothelial dysfunction and pharmacological treatment.
World J Cardiol. 2015 Nov 26;7(11):719-41. doi: 10.4330/wjc.v7.i11.719.
8
Controlled therapeutic gas delivery systems for quality-improved transplants.
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):96-106. doi: 10.1016/j.ejpb.2015.10.009. Epub 2015 Oct 23.
10
Heme as a danger molecule in pathogen recognition.
Free Radic Biol Med. 2015 Dec;89:651-61. doi: 10.1016/j.freeradbiomed.2015.08.020. Epub 2015 Oct 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验